SCHEMBL5458932

SCHEMBL5458932

NC(=O)c1c(NC(=O)Nc2cccs2)sc2c1CCOC2

nearest known ligand 0.58

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CFTR P13569 1/20 0.58
KIF11 P52732 1/20 0.52
ALDH1A1 P00352 3/20 0.51
LMNA P02545 2/20 0.51
HSD17B10 Q99714 2/20 0.51
MAPK10 P53779 1/20 0.51
MEN1 O00255 3/20 0.49
NPC1 O15118 3/20 0.49
RAB9A P51151 3/20 0.49
KMT2A Q03164 3/20 0.49
HPGD P15428 2/20 0.49
KDM4E B2RXH2 1/20 0.49
ESR1 P03372 1/20 0.49
TP53 P04637 1/20 0.49
ALOX15 P16050 1/20 0.49
TSHR P16473 1/20 0.49
MAPK1 P28482 1/20 0.49
CASP1 P29466 1/20 0.49
HTT P42858 1/20 0.49
CASP7 P55210 1/20 0.49

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5455947 0.83 MEN1 (0.65) CFTRALDH1A1LMNAMEN1NPC1
SCHEMBL5467760 0.83 LMNA (0.54) CFTRKIF11ALDH1A1LMNAHSD17B10
SCHEMBL5453210 0.81 CFTR (0.59) CFTRALDH1A1MEN1NPC1RAB9A
SCHEMBL5448477 0.80 CFTR (0.58) CFTRMEN1NPC1RAB9AKMT2A
SCHEMBL16962264 0.80 KCNH2 (0.68) CFTRLMNAMEN1NPC1RAB9A
SCHEMBL5458458 0.80 CFTR (0.57) CFTRALDH1A1HSD17B10MAPK10MEN1
SCHEMBL5460329 0.80 CFTR (0.62) CFTRALDH1A1HSD17B10MAPK10MEN1
SCHEMBL5460547 0.80 MEN1 (0.58) CFTRALDH1A1LMNAMEN1NPC1
SCHEMBL5460654 0.80 ANO1 (0.64) CFTRMEN1NPC1RAB9AKMT2A
SCHEMBL5457966 0.80 ANO1 (0.66) CFTRMEN1NPC1RAB9AKMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20070275962-A1 Heterobicyclic Compounds as Pharmaceutically Active Agents GPC BIOTECH AG (DE) 2007-11-29 US claimed
US-20070275962-A1 Heterobicyclic Compounds as Pharmaceutically Active Agents GPC BIOTECH AG (DE) 2007-11-29 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20070275962-A1 Heterobicyclic Compounds as Pharmaceutically Active Agents TBCA, PARK7, NFATC1 CFTR 2030/4885KIF11 4746/4885ALDH1A1 1153/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.